BriaCell (BCTX) Fundamental Analysis: Revenue, Earnings & Valuation

5.19 / 10

Netural

Fundamental health is modest, scoring 5.2/10. Strengths include strong cash‑to‑market and high inventory turnover; concerns arise from revenue‑to‑market and income‑tax ratios. Asset‑to‑market is neutral. Overall the balance is neither clearly bullish nor bearish.

Analysis Checks(6/10)

Revenue-MV

Value-0.11

Score1/3

Weight12.48%

1M Return4.95%

Total operating revenue (YoY growth rate %)

Value134.00

Score3/3

Weight3.22%

1M Return1.54%

Inventory turnover ratio

Value103.94

Score3/3

Weight16.55%

1M Return6.74%

Gross profit margin (%)

Value41.83

Score1/3

Weight-1.17%

1M Return-0.63%

PB-ROE

Value0.54

Score0/3

Weight8.33%

1M Return3.23%

Income tax / Total profit (%)

Value21.05

Score1/3

Weight-0.95%

1M Return-0.50%

Fixed assets turnover ratio

Value9306.28

Score3/3

Weight2.13%

1M Return1.06%

Cost of sales ratio (%)

Value64.41

Score3/3

Weight9.57%

1M Return4.32%

Asset-MV

Value-0.55

Score3/3

Weight35.13%

1M Return11.84%

Cash-MV

Value0.02

Score2/3

Weight14.70%

1M Return5.94%

Is BCTX fundamentally strong?

BCTX scores 5.19/10 on fundamentals and holds a Fair valuation at present. Backed by its -64.86% ROE, 0.00% net margin, -1.03 P/E ratio, 1.01 P/B ratio, and 69.72% earnings growth, these metrics solidify its Netural investment rating.